LifeStance Health Group, Inc.
LFST
$8.10
$0.172.14%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 165.09% | 116.82% | 90.43% | 89.30% | 79.41% |
| Total Depreciation and Amortization | -12.60% | -22.83% | -28.67% | -30.67% | -25.96% |
| Total Amortization of Deferred Charges | -31.75% | -38.84% | -34.35% | -28.95% | -24.44% |
| Total Other Non-Cash Items | -2.06% | 1.34% | 22.06% | 11.01% | 4.01% |
| Change in Net Operating Assets | 37.02% | -47.42% | 17.97% | 46.42% | 62.27% |
| Cash from Operations | 44.72% | 36.26% | 144.43% | 971.16% | 508.69% |
| Capital Expenditure | -68.11% | -67.51% | -18.13% | 16.39% | 37.64% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -81.41% | -67.51% | -18.13% | 16.39% | 37.64% |
| Total Debt Issued | -- | -- | 778.73% | 778.73% | 398.34% |
| Total Debt Repaid | 98.13% | 97.50% | -10,196.80% | -10,467.25% | -11,011.89% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -801.57% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 7.90% | -20.44% | -24.90% |
| Cash from Financing | -351.79% | -60.40% | -172.56% | -172.06% | -135.06% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -28.77% | 24.19% | 68.79% | 1,284.57% | 550.49% |